Skip to main content
logo
Algorae Pharmaceuticals Limited (ASX:1AI)
Australia flag Australia · Delayed Price · Currency is AUD
0.0120
0.00 (0.00%)
Aug 5, 2026, 3:24 PM AEST

Algorae Pharmaceuticals Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
2481723107
Market Cap Growth
140.08%-50.00%-27.90%127.61%49.95%0.11%
Enterprise Value
226132065
Last Close Price
0.010.010.010.010.010.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
----3019.5725.57
PB Ratio
12.863.795.606.222.554.98
P/TBV Ratio
12.863.795.606.222.554.98

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
----1723.9917.81

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Debt / Equity Ratio
-1.00-1.04-1.03-1.09-1.05-1.17
Net Debt / EBITDA Ratio
--1.822.702.911.21
Net Debt / FCF Ratio
2.682.952.042.072.071.10
Asset Turnover
----0.000.11
Quick Ratio
17.1813.9017.669.3517.846.13
Current Ratio
17.9914.1317.899.3517.846.13
Return on Equity (ROE)
-47.38%-30.63%-61.85%-54.06%-72.33%-68.64%
Return on Assets (ROA)
-39.62%-23.85%-28.78%-22.41%-30.84%-33.30%
Return on Capital Employed (ROCE)
-76.10%-47.90%-56.60%-40.40%-36.20%-97.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-4.17%-9.52%-12.42%-9.01%-19.04%-21.30%
FCF Yield
-2.89%-9.31%-9.03%-8.49%-19.90%-21.32%
Buyback Yield / Dilution
-0.04%-1.46%-23.47%-53.82%-53.24%-